NO990243L - Trovafloxacin-mesylat-tablett - Google Patents

Trovafloxacin-mesylat-tablett

Info

Publication number
NO990243L
NO990243L NO990243A NO990243A NO990243L NO 990243 L NO990243 L NO 990243L NO 990243 A NO990243 A NO 990243A NO 990243 A NO990243 A NO 990243A NO 990243 L NO990243 L NO 990243L
Authority
NO
Norway
Prior art keywords
trovafloxacin mesylate
mesylate tablet
tablet
trovafloxacin
mesylate
Prior art date
Application number
NO990243A
Other languages
English (en)
Other versions
NO990243D0 (no
Inventor
Alton Dale Johnson
Christopher Michael Sinko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO990243D0 publication Critical patent/NO990243D0/no
Publication of NO990243L publication Critical patent/NO990243L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO990243A 1998-01-21 1999-01-20 Trovafloxacin-mesylat-tablett NO990243L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (2)

Publication Number Publication Date
NO990243D0 NO990243D0 (no) 1999-01-20
NO990243L true NO990243L (no) 1999-07-22

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990243A NO990243L (no) 1998-01-21 1999-01-20 Trovafloxacin-mesylat-tablett

Country Status (34)

Country Link
US (1) US6187341B1 (no)
EP (1) EP0930068A3 (no)
JP (1) JPH11269072A (no)
KR (1) KR100314977B1 (no)
CN (1) CN1227743A (no)
AP (1) AP1094A (no)
AR (1) AR012780A1 (no)
AU (1) AU758381B2 (no)
BG (1) BG103106A (no)
BR (1) BR9900116A (no)
CA (1) CA2259698C (no)
CO (1) CO4810225A1 (no)
DZ (1) DZ2712A1 (no)
EA (1) EA003247B1 (no)
GT (1) GT199900004A (no)
HR (1) HRP990023A2 (no)
HU (1) HUP9900154A3 (no)
ID (1) ID23735A (no)
IL (1) IL128051A0 (no)
IS (1) IS4947A (no)
MA (1) MA24747A1 (no)
NO (1) NO990243L (no)
NZ (1) NZ333838A (no)
OA (1) OA10958A (no)
PA (1) PA8466701A1 (no)
PE (1) PE20000169A1 (no)
PL (1) PL330981A1 (no)
SG (1) SG70666A1 (no)
SK (1) SK4299A3 (no)
TN (1) TNSN99007A1 (no)
TR (1) TR199900089A2 (no)
TW (1) TW518224B (no)
YU (1) YU2399A (no)
ZA (1) ZA99393B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200101310T2 (tr) * 1998-11-10 2001-10-22 Bayer Aktiengesellschaft Farmasötik moksifloksasin preparatı.
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
EP1459739B1 (en) * 2003-03-19 2008-01-02 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
DK1828167T3 (da) 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
JP5046946B2 (ja) * 2004-10-15 2012-10-10 スパーナス ファーマシューティカルズ インコーポレイテッド 低乱用性薬学的製剤
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ, インク. Fabiインヒビターとしてのアクリルアミド誘導体
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
TR201909016T4 (tr) 2012-06-19 2019-07-22 Debiopharm Int Sa (E)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamidin ön ilaç türevleri.
AU2017223037B2 (en) 2016-02-26 2022-04-14 Debiopharm International S.A. Medicament for treatment of diabetic foot infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
KR100343909B1 (ko) * 1995-08-29 2003-04-10 화이자 인코포레이티드 트로바플록사신의쯔비터이온형태

Also Published As

Publication number Publication date
CO4810225A1 (es) 1999-06-30
TNSN99007A1 (fr) 2005-11-10
NZ333838A (en) 2000-03-27
TR199900089A3 (tr) 1999-10-21
HUP9900154A2 (hu) 1999-09-28
DZ2712A1 (fr) 2003-09-01
ID23735A (id) 2000-05-11
AU1217399A (en) 1999-08-12
BR9900116A (pt) 2000-05-02
AP9901443A0 (en) 1999-03-31
PA8466701A1 (es) 2000-09-29
AR012780A1 (es) 2000-11-08
NO990243D0 (no) 1999-01-20
EA199900046A2 (ru) 1999-08-26
SK4299A3 (en) 2000-06-12
KR100314977B1 (ko) 2001-11-24
TR199900089A2 (xx) 1999-10-21
HUP9900154A3 (en) 2000-12-28
OA10958A (en) 2001-10-31
KR19990068014A (ko) 1999-08-25
SG70666A1 (en) 2000-02-22
EP0930068A3 (en) 1999-12-22
IS4947A (is) 1999-07-22
MA24747A1 (fr) 1999-10-01
AP1094A (en) 2002-08-19
PL330981A1 (en) 1999-08-02
BG103106A (en) 1999-08-31
CN1227743A (zh) 1999-09-08
US6187341B1 (en) 2001-02-13
YU2399A (sh) 2002-06-19
EP0930068A2 (en) 1999-07-21
CA2259698C (en) 2003-04-15
HRP990023A2 (en) 1999-08-31
ZA99393B (en) 2000-07-21
CA2259698A1 (en) 1999-07-21
HU9900154D0 (en) 1999-03-29
EA199900046A3 (ru) 1999-12-29
JPH11269072A (ja) 1999-10-05
AU758381B2 (en) 2003-03-20
IL128051A0 (en) 1999-11-30
PE20000169A1 (es) 2000-03-10
TW518224B (en) 2003-01-21
EA003247B1 (ru) 2003-02-27
GT199900004A (es) 2000-07-08

Similar Documents

Publication Publication Date Title
NO2007002I1 (no) Sorafenib
NO990243L (no) Trovafloxacin-mesylat-tablett
ID26447A (id) Turunan eritropoietin
IS5869A (is) Hraðlosandi tafla
FI982344A (fi) Tilaa säästävä matkaviestilaite
ATE195121T1 (de) Paroxetinmethansulfonat
NO990431D0 (no) Golfk°llehode
DK1275397T3 (da) Lægemiddel til lokal anvendelse
ID25991A (id) Gesper bukaan samping
DE60044181D1 (de) Gleitvorrichtung
ATE237529T1 (de) Tablettenspender
DE50009171D1 (de) Co 2 - kompressor
DE29801440U1 (de) Tabletten-Einnahmehilfe
DE29813269U1 (de) Tablette
UA2845S (uk) Таблетка
DE69924458D1 (de) Dachgaube
FI980676A (fi) Jalustarakenne
ATA111699A (de) Rechenhilfe
ATA203199A (de) Ablauf
FI990508A0 (fi) Liukurata
UA2855S (uk) Таблетка фармацевтична
DE29810189U1 (de) Tablettausgabeautomat
DE29909139U1 (de) Übungsparcour
PT9554T (pt) Eolia horizontal
DE69920313D1 (de) Dachgaube

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application